The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms

Journal of Molecular Neuroscience

Volumn 61, Issue 2, 2017, Pages 235-246

  MacDougall, Gabriella ^a,b,c   Anderton, Ryan S ^b,c   Edwards, Adam B ^a,b,c   Knuckey, Neville W ^a,b,d   Meloni, Bruno P ^a,b,d  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c Unviersity of Notre Dame   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Calcium influx; Endocytosis; Glutamate excitotoxicity; Neuroprotection; NR2B receptor subunit; Poly arginine peptides

Indexed keywords

AMILORIDE; BETA CYCLODEXTRIN; CELL SURFACE PROTEIN; CYTOCHALASIN B; DYNASORE; GLUTAMIC ACID; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NEUROPROTECTIVE AGENT; NYSTATIN; PHENOTHIAZINE; POLYARGININE; POLYARGININE R12; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; WORTMANNIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR2B NMDA RECEPTOR; PEPTIDE;

ANIMAL CELL; ARTICLE; BRAIN CELL; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYMATIC DEGRADATION; EXCITOTOXICITY; NERVE CELL; NEUROPROTECTION; NONHUMAN; RAT; WESTERN BLOTTING; ANIMAL; BRAIN CORTEX; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; DRUG EFFECTS; ENDOCYTOSIS; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CEREBRAL CORTEX; ENDOCYTOSIS; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84995783626     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-016-0861-1     Document Type: Article

References (54)

1. Aarts M, Liu Y, Liu L, Besshoh S, Arundine M, Gurd JW, Wang Y, Salter MW, Tymianski M (2002) Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science (New York, N.Y.) 298(5594):846–850. doi:10.1126/science.1072873
2. Åmand HL, Rydberg HA, Fornander LH, Lincoln P, Nordén B, Esbjörner EK (2012) Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans. BBA-Biomembranes 1818(11):2669–2678. doi:10.1016/j.bbamem.2012.06.006
3. Bechara C, Sagan S (2013) Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett 587(12):1693–1702. doi:10.1016/j.febslet.2013.04.031
4. Ben-Dov N, Korenstein R (2013) Proton-induced endocytosis is dependent on cell membrane fluidity, lipid-phase order and the membrane resting potential. BBA-Biomembranes 1828(11):2672–2681. doi:10.1016/j.bbamem.2013.07.027
5. Birk AV, Liu S, Soong YY, Mills W, Singh P, Warren JD, Seshan SV, Pardee JD, Szeto HH (2013) The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. JASN 24(8):1250–1261. doi:10.1681/ASN.2012121216
6. Birk AV, Chao WM, Liu S, Soong Y, Szeto HH (2015) Disruption of cytochrome c heme coordination is responsible for mitochondrial injury during ischemia. BBA-Bioenerg 1847:1075–1084. doi:10.1016/j.bbabio.2015.06.006
7. Blouin CM, Lamaze C (2013) Interferon gamma receptor: the beginning of the journey. Front Immunol 4:267. doi:10.3389/fimmu.2013.00267
8. Brittain JM, Chen L, Wilson SM, Brustovetsky T, Gao X, Ashpole NM, Molosh AI, You H, Hudmon A, Shekhar A, White FA, Zamponi GW, Brustovetsky N, Chen J, Khanna R (2011) Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2). J Biol Chem 286(43):37778–37792. doi:10.1074/jbc.M111.255455
9. Brock R (2014) The uptake of arginine-rich cell-penetrating peptides: putting the puzzle together. Bioconjug Chem 25(5):863–868. doi:10.1021/bc500017t
10. 2+ exchanger and regulates their functional activity. J Biol Chem 289(11):7470–7482. doi:10.1074/jbc.M113.518472
11. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22(9):391–397. doi:10.1016/S0166-2236(99)01401-0
12. Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78:857–902. doi:10.1146/annurev.biochem.78.081307.110540
13. Duchardt F, Fotin-Mleczek M, Schwarz H, Fischer R, Brock R (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8(7):848–866. doi:10.1111/j.1600-0854.2007.00572.x
14. Fan J, Cowan CM, Zhang LYJ, Hayden MR, Raymond LA (2009) Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington’s disease. J Neurosci 29(35):10928–10938. doi:10.1523/JNEUROSCI.2491-09.2009
15. Feldman P, Khanna R (2013) Challenging the catechism of therapeutics for chronic neuropathic pain: targeting CaV2.2 interactions with CRMP2 peptides. Neurosci Lett 17(557 PtA):27–36. doi:10.1016/j.neulet.2013.06.057
16. Ferré CA, Davezac N, Thouard A, Peyrin JM, Belenguer P, Miquel MC, Gonzalez-Dunia D, Szelechowski M (2016) Manipulation of the N-terminal sequence of the Borna disease virus X protein improves its mitochondrial targeting and neuroprotective potential. FASEB J 30(4):1523–1533. doi:10.1096/fj.15-279620
17. Ferrer-Montiel AV, Merino JM, Blondelle SE, Perez-Payà E, Houghten RA, Montal M (1998) Selected peptides targeted to the NMDA receptor channel protect neurons from excitotoxic death. Nat Biotechnol 16(3):286–291. doi:10.1038/nbt0398-286
18. Fotin-Mleczek M, Welte S, Mader O, Duchardt F, Fischer R, Hufnagel H, Scheurich P, Brock R (2005) Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J Cell Sci 118(Pt 15):3339–3351. doi:10.1242/jcs.02460
19. García-Caballero A, Gadotti VM, Stemkowski P, Weiss N, Souza IA, Hodgkinson V, Bladen C, Chen L, Hamid J, Pizzoccaro A, Deage M, François A, Bourinet E, Zamponi GW (2014) The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity. Neuron 83(5):1144–1158. doi:10.1016/j.neuron.2014.07.036
20. Hoque A, Hossain MI, Ameen SS, Ang CS, Williamson N, Ng DCH, Chueh AC, Roulston C, Cheng HC (2016) A beacon of hope in stroke therapy—blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies. Pharmacol Ther 160:159–179. doi:10.1016/j.pharmthera.2016.02.009
21. Hussain KM, Leong KLJ, Ng MM, Chu JJH (2011) The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J Biol Chem 286(1):309–321. doi:10.1074/jbc.M110.168468
22. Jiao CY, Delaroche D, Burlina F, Alves ID, Chassaing G, Sagan S (2009) Translocation and endocytosis for cell-penetrating peptide internalization. J Biol Chem 284(49):33957–33965. doi:10.1074/jbc.M109.056309
23. Kanekiyo T, Zhang J, Liu Q, Liu C, Zhang L, Bu G (2011) Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J Neurosci 31(5):1644–1651. doi:10.1523/JNEUROSCI.5491-10.2011
24. Lau A, Tymianski M (2010) Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch - Eur J Physiol 460(2):525–542. doi:10.1007/s00424-010-0809-1
25. Li Q, So CR, Fegan A, Cody V, Sarikaya M, Vallera DA, Wagner CR (2010) Chemically self-assembled antibody nanorings (CSANs): design and characterization of an anti-CD3 IgM biomimetic. J Am Chem Soc 132(48):17247–17257. doi:10.1021/ja107153a
26. Loftis JM, Janowsky A (2003) The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 97(1):55–85
27. Lu W, Ma H, Sheng ZH, Mochida S (2009) Dynamin and activity regulate synaptic vesicle recycling in sympathetic neurons. J Biol Chem 284(3):1930–1937. doi:10.1074/jbc.M803691200
28. Marshall J, Wong KY, Rupasinghe CN, Tiwari R, Zhao X, Berberoglu ED, Sinkler C, Liu J, Lee I, Parang K, Spaller MR, Hüttemann M, Goebel DJ (2015) Inhibition of N-methyl-d-aspartate-induced retinal neuronal death by polyarginine peptides is linked to the attenuation of stress-induced hyperpolarization of the inner mitochondrial membrane potential. J Biol Chem 290(36):22030–22048. doi:10.1074/jbc.M115.662791
29. Meloni BP, Majda BT, Knuckey NW (2001) Establishment of neuronal in vitro models of ischemia in 96-well microtiter strip-plates that result in acute, progressive and delayed neuronal death. Neuroscience 108(1):17–26. doi:10.1016/j.pharmthera.2015.06.002
30. Meloni BP, Craig AJ, Milech N, Hopkins RM, Watt PM, Knuckey NW (2014) The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures. Cell Mol Neurobiol 34:173–181. doi:10.1007/s10571-013-9999-3
31. Meloni BP, Brookes LM, Clark VW, Cross JL, Edwards AB, Anderton RS, Hopkins RM, Hoffman K, Knuckey NW (2015a) Poly-arginine and arginine-rich peptides are neuroprotective in stroke models. J Cereb Blood Flow Metab 35(6):993–1004. doi:10.1038/jcbfm.2015.11
32. Meloni BP, Milani D, Edwards AB, Anderton RS, O’Hare Doig RL, Fitzgerald M, Palmer TN, Knuckey NW (2015b) Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties. Pharmacol Ther 153:36–54. doi:10.1016/j.pharmthera.2015.06.002
33. Milani D, Clark VW, Cross JL, Anderton RS, Knuckey NW, Meloni BP (2016a) Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model. BMC Neurosci 17(1):1–8. doi:10.1186/s12868-016-0253-z
34. Milani D, Knuckey NW, Anderton RS, Cross JL, Meloni BP (2016b) The R18 polyarginine peptide is more effective than the TAT-NR2B9c (NA-1) peptide when administered 60 minutes after permanent middle cerebral artery occlusion in the rat. Stroke Res Treat 2016:1–9. doi:10.1155/2016/2372710Article ID 237271
35. Milani D, Cross JL, Anderton RS, Blacker DJ, Knuckey NW, Meloni BP (2016c) Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat. Neurosci Res. doi:10.1016/j.neures.2016.09.002In press
36. Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pep Res 56(5):318–325. doi:10.1034/j.1399-3011.2000.00723.x
37. Nichols B (2009) Endocytosis of lipid-anchored proteins: excluding GEECs from the crowd. J Cell Biol 186(4):457–459. doi:10.1083/jcb.200907119
38. Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Bio 4(7):552–565. doi:10.1038/nrm1150
39. 2+ transfer in the control of apoptosis. Oncogene 27(50):6407–6418. doi:10.1038/onc.2008.308
40. Planells-Cases R, Aracil A, Merino JM, Gallar J, Pérez-Payá E, Belmonte C, González-Ros JM, Ferrer-Montiel AV (2000) Arginine-rich peptides are blockers of VR-1 channels with analgesic activity. FEBS Lett 481(2):131–136. doi:10.1016/S0014-5793(00)01982-7
41. Rigobello MP, Barzon E, Marin O, Bindoli A (1995) Effect of polycation peptides on mitochondrial permeability transition. Biochem Bioph Res Co 217(1):144–149. doi:10.1006/bbrc.1995.2756
42. Rothbard JB, Kreider E, VanDeusen CL, Wright L, Wylie BL, Wender PA (2002) Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J Med Chem 45(17):3612–3618. doi:10.1021/jm0105676
43. Rothbard JB, Jessop TC, Wender PA (2005) Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv Drug Deliver Rev 57:495–504. doi:10.1016/j.addr.2004.10.0034 SPEC.ISS.
44. Sabharanjak S, Sharma P, Parton RG, Mayor S (2002) GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated clathrin-independent pinocytic pathway. Dev Cell 2(4):411–423. doi:10.1016/S1534-5807(02)00145-4
45. Sai Y, Kajita M, Tamai I, Wakama J, Wakamiya T, Tsuji A (1998) Adsorptive-mediated endocytosis of a basic peptide in enterocyte-like caco-2 cells. Am J Physiol Gastrointest Liver Physiol 275(3):514–520
46. Salińska E, Danysz W, Łazarewicz JW (2005) The role of excitotoxicity in neurodegeneration. Folia Neuropathol 43(4):322–339
47. Sinai L, Duffy S, Roder JC (2010) Src inhibition reduces NR2B surface expression and synaptic plasticity in the amygdala. Learn Memory 17(8):364–371. doi:10.1101/lm.1765710
48. Soane L, Fiskum G (2005) TAT-mediated endocytotic delivery of the loop deletion Bcl-2 protein protects neurons against cell death. J Neurochem 95(1):230–243. doi:10.1111/j.1471-4159.2005.03359.x
49. Su Y, Doherty T, Waring AJ, Ruchala P, Hong M (2009) Roles of arginine and lysine residues in the translocation of a cell-penetrating peptide from13C, 31P, and19F solid-state NMR. Biochemistry 48(21):4587–4595. doi:10.1021/bi900080d
50. Szelechowski M, Bétourné A, Monnet Y, Ferré CA, Thouard A, Foret C, Peyrin JM, Hunot S, Gonzalez-Dunia D (2014) A viral peptide that targets mitochondria protects against neuronal degeneration in models of Parkinson’s disease. Nat Commun 5:5181. doi:10.1038/ncomms6181
51. Tu W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian MM, Balel C, Wang M, Jia N, Zhang W, Lew F, Chan SL, Chen Y, Lu Y (2010) DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140(2):222–234. doi:10.1016/j.cell.2009.12.055
52. Vendeville A, Rayne F, Bonhoure A, Bettache N, Montcourrier P, Beaumelle B (2004) HIV-1 tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol Biol Cell 15(5):2347–2360. doi:10.1091/mbc.E03-12-0921
53. Walrant A, Correia I, Jiao CY, Lequin O, Bent EH, Goasdoué N, Lacombe C, Chassaing G, Sagan S, Alves ID (2011) Different membrane behaviour and cellular uptake of three basic arginine-rich peptides. BBA-Biomembranes 1808(1):382–393. doi:10.1016/j.bbamem.2010.09.009
54. Wender PA, Galliher WC, Goun EA, Jones LR, Pillow TH (2008) The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliver Rev 60(4–5):452–472. doi:10.1016/j.addr.2007.10.016